|
1
|
Sonneveld P, Avet-Loiseau H, Lonial S,
Usmani S, Siegel D, Anderson KC, Chng WJ, Moreau P, Attal M, Kyle
RA, et al: Treatment of multiple myeloma with high-risk
cytogenetics: A consensus of the International Myeloma Working
Group. Blood. 127:2955–2962. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mimura N, Hideshima T and Anderson KC:
Novel therapeutic strategies for multiple myeloma. Exp Hematol.
43:732–741. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao JR, Qin XJ, Jiang H, Gao YC, Guo MF
and Jiang NN: Potential role of lncRNAs in contributing to
pathogenesis of chronic glomerulonephritis based on microarray
data. Gene. 643:46–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duguang L, Jin H, Xiaowei Q, Peng X,
Xiaodong W, Zhennan L, Jianjun Q and Jie Y: The involvement of
lncRNAs in the development and progression of pancreatic cancer.
Cancer Biol Ther. 18:927–936. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng YB, He X, Huang YF, Wu QN, Zhou YC
and Hao DJ: Long noncoding RNA CRNDE promotes multiple myeloma cell
growth by suppressing miR-451. Oncol Res. 25:1207–1214. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li B, Shi C, Zhao J and Li B: Long
noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect
of miR-410 on the down-regulation of ITPKB in human HCT-116 and
HCT-8 cells. Oncotarget. 8:92855–92863. 2017.PubMed/NCBI
|
|
7
|
Gu Y, Xiao X and Yang S: LncRNA MALAT1
acts as an oncogene in multiple myeloma through sponging miR-509-5p
to modulate FOXP1 expression. Oncotarget. 8:101984–101993. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Niu XB, Fu GB, Wang L, Ge X, Liu WT, Wen
YY, Sun HR, Liu LZ, Wang ZJ and Jiang BH: Insulin-like growth
factor-I induces chemoresistence to docetaxel by inhibiting miR-143
in human prostate cancer. Oncotarget. 8:107157–107166. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun J, Li W, Sun Y, Yu D, Wen X, Wang H,
Cui J, Wang G, Hoffman AR and Hu JF: A novel antisense long
noncoding RNA within the IGF1R gene locus is imprinted in
hematopoietic malignancies. Nucleic Acids Res. 42:9588–9601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang L, Sun J, Wen X, Cui J, Wang G,
Hoffman AR, Hu JF and Li W: Aberrant allele-switch imprinting of a
novel IGF1R intragenic antisense non-coding RNA in breast cancers.
Eur J Cancer. 51:260–270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Merz M, Jauch A, Hielscher T, Bochtler T,
Schönland SO, Seckinger A, Hose D, Bertsch U, Neben K, Raab MS, et
al: Prognostic significance of cytogenetic heterogeneity in
patients with newly diagnosed multiple myeloma. Blood Adv. 2:1–9.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen X, Zhang Y, Wu X, Guo Y, Shi W, Qi J,
Cong H, Wang X, Wu X and Ju S: Upregulated lncRNA-PCAT1 is closely
related to clinical diagnosis of multiple myeloma as a predictive
biomarker in serum. Cancer Biomark. 18:257–263. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sedlarikova L, Gromesova B, Kubaczkova V,
Radova L, Filipova J, Jarkovsky J, Brozova L, Velichova R, Almasi
M, Penka M, et al: Deregulated expression of long non-coding RNA
UCA1 in multiple myeloma. Eur J Haematol. 99:223–233. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cho SF, Chang YC, Chang CS, Lin SF, Liu
YC, Hsiao HH, Chang JG and Liu TC: MALAT1 long non-coding RNA is
overexpressed in multiple myeloma and may serve as a marker to
predict disease progression. BMC Cancer. 14:8092014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng J, Sun Y, Zhang EB, Lu XY, Jin SD and
Guo RH: A novel long noncoding RNA IRAIN regulates cell
proliferation in non small cell lung cancer. Int J Clin Exp Pathol.
8:12268–12275. 2015.PubMed/NCBI
|
|
17
|
Lian Y, Wang J, Feng J, Ding J, Ma Z, Li
J, Peng P, De W and Wang K: Long non-coding RNA IRAIN suppresses
apoptosis and promotes proliferation by binding to LSD1 and EZH2 in
pancreatic cancer. Tumour Biol. 37:14929–14937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Tan G, Dong L, Cheng L, Li K, Wang
Z and Luo H: Circulating MiR-125b as a marker predicting
chemoresistance in breast cancer. PLoS One. 7:e342102012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen Y, Xu H, Pan X, Wu W, Wang H, Yan L,
Zhang M, Liu X, Xia S and Shao Q: miR-34a and miR-125b are
upregulated in peripheral blood mononuclear cells from patients
with type 2 diabetes mellitus. Exp Ther Med. 14:5589–5596.
2017.PubMed/NCBI
|
|
20
|
Piatopoulou D, Avgeris M, Marmarinos A,
Xagorari M, Baka M, Doganis D, Kossiva L, Scorilas A and Gourgiotis
D: miR-125b predicts childhood acute lymphoblastic leukaemia poor
response to BFM chemotherapy treatment. Br J Cancer. 117:801–812.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li F, Huang C, Li Q and Wu X: Construction
and comprehensive analysis for dysregulated long non-coding RNA
(lncRNA)-associated competing endogenous RNA (ceRNA) network in
gastric cancer. Med Sci Monit. 24:37–49. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao Y, Wang H, Wu C, Yan M, Wu H, Wang J,
Yang X and Shao Q: Construction and investigation of
lncRNA-associated ceRNA regulatory network in papillary thyroid
cancer. Oncol Rep. 39:1197–1206. 2018.PubMed/NCBI
|
|
23
|
Zhang S, Dong X, Ji T, Chen G and Shan L:
Long non-coding RNA UCA1 promotes cell progression by acting as a
competing endogenous RNA of ATF2 in prostate cancer. Am J Transl
Res. 9:366–375. 2017.PubMed/NCBI
|
|
24
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
